AP-003(Altum Pharmaceuticals)

N/A

Report date: 2022/11/07 10:32:37

Base Information

Drug NameAP-003(Altum Pharmaceuticals)
Drug Alias NameInterferon-Alpha2BInterferon-Alpha-2BInhaled Interferon α2bAP-003IFNa-2b
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryChileMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesAltum Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesThe Children'S Hospital Of Fudan UniversityPontificia Universidad Catolica De ChileAltum Pharmaceuticals Inc +[4] 
Inactive CompaniesShanghai Children'S Medical Center Shanghai Jiaotong University School Of Medicine
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A